ImmunoGen, Inc.: insider trading
392 trades by 31 directors, officers and 10% owners since 2009, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$0
0 sales by 0 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (31)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Daniel CharSVP & CHIEF LEGAL OFFICER | 0 | — | — | |
| Dean J. MitchellDirector | 0 | — | — | |
| Helen M. ThackrayDirector | 0 | — | — | |
| Mark Alan GoldbergDirector | 0 | — | — | |
| Mark J. EnyedyCHIEF EXECUTIVE OFFICER, Director | 0 | — | — | |
| Michael VasconcellesEVP R&D & MEDICAL AFFAIRS | 0 | — | — | |
| Renee LentiniVP & PRIN ACCTG OFFICER | 0 | — | — | |
| Richard John WallaceDirector | 0 | — | — | |
| Stacy Ann CoenSVP & CHIEF BUSINESS OFFICER | 0 | — | — | |
| Stuart A. ArbuckleDirector | 0 | — | — | |
| Theresa WingroveSVP OF REGULATORY AFFAIRS | 0 | — | — | |
| Kristine PetersonDirector | 0 | — | — | |
| Stephen C. McCluskiDirector | 0 | — | — | |
| Anna BerkenblitSVP & CHIEF MEDICAL OFFICER | 113,935 | — | — | |
| Kristen Harrington-SmithSVP & CHIEF COMMERCIAL OFFICER | 25,000 | — | — | |
| Thomas RyllSVP, Technical Operations | 84,714 | — | — | |
| David G. FosterV.P.-Fin., Prin. Acctg. Off. | 38,274 | — | — | |
| Craig BarrowsExecutive VP, General Counsel | 145,275 | — | — | |
| Blaine H. McKeeEVP & Chief Business Officer | 5,230 | — | — | |
| Richard J. GregoryExecutive VP & CSO | 236,056 | — | — | |
| David Brannon JohnstonChief Financial Officer | 180,690 | — | — | |
| Daniel M. JuniusDirector | 184,987 | — | — | |
| Peter J. WilliamsVP, Business Development | 50,620 | — | — | |
| John LambertExecutive Vice President | 120,521 | — | — | |
| Charles Q. MorrisExecutive VP & CDO | 27,090 | — | — | |
| Nicole OnettoDirector | 0 | — | — | |
| Gregory D. PerryChief Financial Officer | 0 | — | — | |
| James J. O'LearyVice President | 0 | — | — | |
| Mitchel SayareDirector | 383,136 | — | — | |
| David Warren CarterDirector | 0 | — | — | |
| Howard H. PienDirector | 0 | — | — |
Trades#
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Mark Alan GoldbergDirector | Buy | +30,000 | $5.760 | $173 K | 53,800 | Form 4 |
| filed | Mark Alan GoldbergDirector | Buy | +20,000 | $1.800 | $36 K | 23,800 | Form 4 |
| filed | Mark J. EnyedyChief Executive Officer, Director | Buy | +25,000 | $1.830 | $46 K | 100,100 | Form 4 |
| filed | Craig BarrowsVice-President,General Counsel | Buy | +10,000 | $1.710 | $17 K | 31,100 | Form 4 |
| filed | John LambertExecutive Vice President | Buy | +2,775 | $1.690 | $5 K | 120,521 | Form 4 |
| filed | Richard J. GregoryExecutive VP & CSO | Buy | +16,600 | $1.780 | $30 K | 39,231 | Form 4 |
| filed | David Brannon JohnstonChief Financial Officer | Buy | +10,000 | $1.700 | $17 K | 10,000 | Form 4 |
| filed | Dean J. MitchellDirector | Buy | +10,000 | $12.51 | $125 K | 10,000 | Form 4 |
| filed | Mark Alan GoldbergDirector | Buy | +3,000 | $11.27 | $34 K | 3,800 | Form 4 |